Yersinia enterocolitis mimicking Crohn's disease in a toddler

A M Tuohy1, M O'Gorman, C Byington

  • 1Department of, University of Utah School of Medicine, Primary Children's Medical Center, Salt Lake City, Utah 84113-1100, USA.

Pediatrics
|September 2, 1999
PubMed

Insights

Pediatric Yersinia enterocolitis can mimic Crohn's disease, presenting with severe gastrointestinal symptoms and inflammation. Prompt identification and antibiotic treatment are crucial for recovery.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Yersinia enterocolitica infection can present with diverse clinical manifestations in children.
  • Distinguishing infectious colitis from inflammatory bowel disease is a diagnostic challenge.

Observation:

  • A 3.5-year-old girl exhibited symptoms of persistent abdominal pain, fever, vomiting, diarrhea, rash, oral ulceration, and anemia.
  • Imaging revealed ileocecal edema and mesenteric adenopathy; colonoscopy showed colitis, and enteroclysis demonstrated terminal ileum inflammation.

Findings:

  • Initial diagnosis considered Crohn's disease due to clinical deterioration despite antibiotics.
  • Yersinia enterocolitica was identified on hospital day nine, leading to trimethoprim/sulfamethoxazole treatment.
  • The patient showed prompt clinical improvement after initiating appropriate antibiotic therapy.

Implications:

  • This case highlights the importance of considering infectious etiologies, such as Yersinia enterocolitis, in pediatric patients with suspected inflammatory bowel disease.
  • The comprehensive clinical description provides valuable insights into the diagnostic challenges and presentation of Yersinia enterocolitis in children.
  • Early and accurate diagnosis of Yersinia enterocolitis can prevent unnecessary immunosuppressive therapy and guide appropriate antimicrobial treatment.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...